43 related articles for article (PubMed ID: 15933498)
1. Radiation response genotype and risk of differentiated thyroid cancer: a case-control analysis.
Sturgis EM; Zhao C; Zheng R; Wei Q
Laryngoscope; 2005 Jun; 115(6):938-45. PubMed ID: 15933498
[TBL] [Abstract][Full Text] [Related]
2. Role of DNA Repair Variants and Diagnostic Radiology Exams in Differentiated Thyroid Cancer Risk: A Pooled Analysis of Two Case-Control Studies.
Zidane M; Truong T; Lesueur F; Xhaard C; Cordina-Duverger E; Boland A; Blanché H; Ory C; Chevillard S; Deleuze JF; Souchard V; Ren Y; Zemmache MZ; Canale S; Borson-Chazot F; Schvartz C; Mariné Barjoan E; Guizard AV; Laurent-Puig P; Mulot C; Guibon J; Karimi M; Schlumberger M; Adjadj E; Rubino C; Guenel P; Cazier JB; de Vathaire F
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1208-1217. PubMed ID: 33827984
[TBL] [Abstract][Full Text] [Related]
3. Common variants at the 9q22.33, 14q13.3 and ATM loci, and risk of differentiated thyroid cancer in the Cuban population.
Pereda CM; Lesueur F; Pertesi M; Robinot N; Lence-Anta JJ; Turcios S; Velasco M; Chappe M; Infante I; Bustillo M; García A; Clero E; Xhaard C; Ren Y; Maillard S; Damiola F; Rubino C; Salazar S; Rodriguez R; Ortiz RM; de Vathaire F
BMC Genet; 2015 Mar; 16():22. PubMed ID: 25879635
[TBL] [Abstract][Full Text] [Related]
4. Common variants at 9q22.33, 14q13.3, and ATM loci, and risk of differentiated thyroid cancer in the French Polynesian population.
Maillard S; Damiola F; Clero E; Pertesi M; Robinot N; Rachédi F; Boissin JL; Sebbag J; Shan L; Bost-Bezeaud F; Petitdidier P; Doyon F; Xhaard C; Rubino C; Blanché H; Drozdovitch V; Lesueur F; de Vathaire F
PLoS One; 2015; 10(4):e0123700. PubMed ID: 25849217
[TBL] [Abstract][Full Text] [Related]
5. Gene network and biological pathways associated with susceptibility to differentiated thyroid carcinoma.
Kulkarni O; Sugier PE; Guibon J; Boland-Augé A; Lonjou C; Bacq-Daian D; Olaso R; Rubino C; Souchard V; Rachedi F; Lence-Anta JJ; Ortiz RM; Xhaard C; Laurent-Puig P; Mulot C; Guizard AV; Schvartz C; Boutron-Ruault MC; Ostroumova E; Kesminiene A; Deleuze JF; Guénel P; De Vathaire F; Truong T; Lesueur F
Sci Rep; 2021 Apr; 11(1):8932. PubMed ID: 33903625
[TBL] [Abstract][Full Text] [Related]
6. Genetic susceptibility may modify the association between cell phone use and thyroid cancer: A population-based case-control study in Connecticut.
Luo J; Li H; Deziel NC; Huang H; Zhao N; Ma S; Ni X; Udelsman R; Zhang Y
Environ Res; 2020 Mar; 182():109013. PubMed ID: 31918310
[TBL] [Abstract][Full Text] [Related]
7. [DNA double-strand breaks repair capacity and risk of differentiated thyroid cancer: a case-control study].
Qin JL; Shi XY; Fan J; Liu ST; Li G; Wu JF; Zhang M
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Feb; 56(2):133-137. PubMed ID: 33548942
[No Abstract] [Full Text] [Related]
8. Common genetic variants in pituitary-thyroid axis genes and the risk of differentiated thyroid cancer.
Pastor S; Akdi A; González ER; Castell J; Biarnés J; Marcos R; Velázquez A
Endocr Connect; 2012 Nov; 1(2):68-77. PubMed ID: 23781307
[TBL] [Abstract][Full Text] [Related]
9. Genetic signature of differentiated thyroid carcinoma susceptibility: a machine learning approach.
Brigante G; Lazzaretti C; Paradiso E; Nuzzo F; Sitti M; Tüttelmann F; Moretti G; Silvestri R; Gemignani F; Försti A; Hemminki K; Elisei R; Romei C; Zizzi EA; Deriu MA; Simoni M; Landi S; Casarini L
Eur Thyroid J; 2022 Oct; 11(5):. PubMed ID: 35976137
[TBL] [Abstract][Full Text] [Related]
10. Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 2q35 and 8p12 in Europeans, Melanesians and Polynesians.
Guibon J; Sugier PE; Kulkarni O; Karimi M; Bacq-Daian D; Besse C; Boland A; Adjadj E; Rachédi F; Rubino C; Xhaard C; Mulot C; Laurent-Puig P; Guizard AV; Schvartz C; Ortiz RM; Ren Y; Ostroumova E; Deleuze JF; Boutron-Ruault MC; Kesminiene A; De Vathaire F; Guénel P; Lesueur F; Truong T
Oncotarget; 2021 Mar; 12(5):493-506. PubMed ID: 33747362
[TBL] [Abstract][Full Text] [Related]
11. A Meta-Analysis for Association of XRCC1, XRCC2 and XRCC3 Polymorphisms with Susceptibility to Thyroid Cancer.
Mandegari M; Dastgheib SA; Asadian F; Shaker SH; Tabatabaie SM; Kargar S; Sadeghizadeh-Yazdi J; Neamatzadeh H
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2221-2236. PubMed ID: 34319046
[TBL] [Abstract][Full Text] [Related]
12. Thyroid Cancer: The Quest for Genetic Susceptibility Involving DNA Repair Genes.
Santos LS; Gomes BC; Bastos HN; Gil OM; Azevedo AP; Ferreira TC; Limbert E; Silva SN; Rueff J
Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31374908
[TBL] [Abstract][Full Text] [Related]
13. Association Between X-Ray Cross-complementing Group 3 (XRCC3) Thr241Met Polymorphism and Risk of Thyroid Cancer: A Meta-Analysis.
Lu W; Wu G; Zhang B
Med Sci Monit; 2015 Dec; 21():3978-85. PubMed ID: 26687776
[TBL] [Abstract][Full Text] [Related]
14. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
[TBL] [Abstract][Full Text] [Related]
15. Significant associations between X-ray repair cross-complementing group 3 genetic polymorphisms and thyroid cancer risk.
Yu XL; Liu H; Wang B; Fu ZJ; Yuan Y; Yan SL; Zhao WJ; Wang YG; Cai J
Tumour Biol; 2014 Mar; 35(3):2009-15. PubMed ID: 24277376
[TBL] [Abstract][Full Text] [Related]
16. Single nucleotide polymorphism rs17849071 G/T in the PIK3CA gene is inversely associated with follicular thyroid cancer and PIK3CA amplification.
Xing JC; Tufano RP; Murugan AK; Liu D; Wand G; Ladenson PW; Xing M; Trink B
PLoS One; 2012; 7(11):e49192. PubMed ID: 23185308
[TBL] [Abstract][Full Text] [Related]
17. The role of Ile3434Thr XRCC7 gene polymorphism in differentiated thyroid cancer risk in an Iranian population.
Rahimi M; Fayaz S; Fard-Esfahani A; Modarressi MH; Akrami SM; Fard-Esfahani P
Iran Biomed J; 2012; 16(4):218-22. PubMed ID: 23183621
[TBL] [Abstract][Full Text] [Related]
18. Association of BRCA1 functional single nucleotide polymorphisms with risk of differentiated thyroid carcinoma.
Xu L; Doan PC; Wei Q; Liu Y; Li G; Sturgis EM
Thyroid; 2012 Jan; 22(1):35-43. PubMed ID: 22136207
[TBL] [Abstract][Full Text] [Related]
19. Family history of cancer and risk of sporadic differentiated thyroid carcinoma.
Xu L; Li G; Wei Q; El-Naggar AK; Sturgis EM
Cancer; 2012 Mar; 118(5):1228-35. PubMed ID: 21800288
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
